Yi Wen Kong

3.6k total citations · 1 hit paper
42 papers, 2.7k citations indexed

About

Yi Wen Kong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yi Wen Kong has authored 42 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Yi Wen Kong's work include MicroRNA in disease regulation (7 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (5 papers). Yi Wen Kong is often cited by papers focused on MicroRNA in disease regulation (7 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (5 papers). Yi Wen Kong collaborates with scholars based in United States, China and United Kingdom. Yi Wen Kong's co-authors include Martin Bushell, Thomas J. Jackson, David Ferland-McCollough, Ian G. Cannell, Anne E. Willis, Michael B. Yaffe, Daoquan Peng, Hedda A. Meijer, Xin Su and Helen C. Dobbyn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Yi Wen Kong

40 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

microRNAs in cancer management

2012 636 citations Yi Wen Kong, David Ferland-McCollough et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Wen Kong United States	24	1.8k	1.1k	403	261	154	42	2.7k
Kai Fu China	30	1.8k 1.0×	1.0k 0.9×	255 0.6×	347 1.3×	151 1.0×	121	2.7k
Ziyi Fu China	30	1.8k 1.0×	1.3k 1.1×	255 0.6×	431 1.7×	126 0.8×	121	2.7k
Songwen Ju China	17	2.0k 1.1×	1.1k 1.0×	406 1.0×	195 0.7×	151 1.0×	31	2.7k
Xiaoyi Huang China	25	2.0k 1.1×	1.5k 1.3×	317 0.8×	277 1.1×	84 0.5×	108	2.9k
Shuwei Wang China	21	1.2k 0.7×	891 0.8×	264 0.7×	306 1.2×	224 1.5×	60	2.0k
Yan Gu China	27	1.9k 1.1×	1.3k 1.2×	595 1.5×	419 1.6×	202 1.3×	91	3.0k
Jian Xu China	32	1.8k 1.0×	888 0.8×	472 1.2×	420 1.6×	286 1.9×	112	3.0k
Radhakrishnan Vishnubalaji Qatar	25	1.3k 0.7×	816 0.7×	187 0.5×	359 1.4×	131 0.9×	54	2.2k
Shih Sheng Jiang Taiwan	32	1.5k 0.8×	565 0.5×	266 0.7×	449 1.7×	116 0.8×	91	2.5k

Countries citing papers authored by Yi Wen Kong

Since Specialization

Citations

This map shows the geographic impact of Yi Wen Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Wen Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Wen Kong more than expected).

Fields of papers citing papers by Yi Wen Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Wen Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Wen Kong. The network helps show where Yi Wen Kong may publish in the future.

Co-authorship network of co-authors of Yi Wen Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Wen Kong. A scholar is included among the top collaborators of Yi Wen Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Wen Kong. Yi Wen Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Yi Wen, Fan Tong, Ruiguang Zhang, et al.. (2024). Role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study. Chinese Medical Journal. 138(17). 2130–2138. 1 indexed citations

Zhai, Wei, Wensheng Yang, Xuelian Xiao, et al.. (2024). ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway. Biology Direct. 19(1). 94–94.

Stehn, Justine, Scott Floyd, Erik Wilker, et al.. (2023). MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approach. Frontiers in Molecular Biosciences. 10. 1148933–1148933.

Kong, Yi Wen & Erik C. Dreaden. (2022). PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives. Frontiers in Bioengineering and Biotechnology. 10. 879988–879988. 20 indexed citations

He, Xiangdong, Jing Xue, Lei Shi, et al.. (2021). Recent antioxidative nanomaterials toward wound dressing and disease treatment via ROS scavenging. Materials Today Nano. 17. 100149–100149. 67 indexed citations

Sriram, Ganapathy, Lauren E. Milling, Yi Wen Kong, et al.. (2021). The injury response to DNA damage in live tumor cells promotes antitumor immunity. Science Signaling. 14(705). eabc4764–eabc4764. 41 indexed citations

Lam, Fred C., Yi Wen Kong, & Michael B. Yaffe. (2020). Inducing DNA damage through R-loops to kill cancer cells. Molecular & Cellular Oncology. 8(1). 1848233–1848233. 9 indexed citations

Kong, Yi Wen, Erik C. Dreaden, Sandra Morandell, et al.. (2020). Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints. Nature Communications. 11(1). 4124–4124. 24 indexed citations

Kong, Yi Wen, Ruifang Wu, Suhan Zhang, et al.. (2020). Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2. International Immunopharmacology. 88. 106918–106918. 23 indexed citations

10.

Krismer, Konstantin, Shohreh Varmeh, Erika D. Handly, et al.. (2020). Transite: A Computational Motif-Based Analysis Platform That Identifies RNA-Binding Proteins Modulating Changes in Gene Expression. Cell Reports. 32(8). 108064–108064. 29 indexed citations

11.

Su, Xin, Yi Wen Kong, & Daoquan Peng. (2019). Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clinica Chimica Acta. 498. 30–37. 31 indexed citations

12.

Su, Xin, Yi Wen Kong, & Daoquan Peng. (2019). Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol. Lipids in Health and Disease. 18(1). 134–134. 48 indexed citations

13.

Su, Xin, Yi Wen Kong, & Daoquan Peng. (2018). New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. Lipids in Health and Disease. 17(1). 174–174. 57 indexed citations

14.

Barrett, Christopher D., Hunter B. Moore, Yi Wen Kong, et al.. (2018). Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator–dependent manner. The Journal of Trauma: Injury, Infection, and Critical Care. 86(1). 101–107. 44 indexed citations

15.

Dreaden, Erik C., Yi Wen Kong, Stephen W. Morton, et al.. (2015). Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle. Clinical Cancer Research. 21(19). 4410–4419. 49 indexed citations

16.

Yan, Feng, et al.. (2015). Transforming growth factor-β2 increases the capacity of retinal pigment epithelial cells to induce the generation of regulatory T cells. Molecular Medicine Reports. 13(2). 1367–1372. 5 indexed citations

17.

Lü, Lin, et al.. (2014). [Evaluation on the efficacy of prevention programs and relevant factors targeting mother-to-infant transmission on hepatitis B virus in Yunnan province].. PubMed. 35(2). 114–6. 2 indexed citations

18.

Meijer, Hedda A., Yi Wen Kong, Wei-Ting Lu, et al.. (2013). Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation. Science. 340(6128). 82–85. 252 indexed citations

19.

Kong, Yi Wen, David Ferland-McCollough, Thomas J. Jackson, & Martin Bushell. (2012). microRNAs in cancer management. The Lancet Oncology. 13(6). e249–e258. 636 indexed citations breakdown →

20.

Kong, Yi Wen, Ian G. Cannell, Cornelia H. de Moor, et al.. (2008). The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proceedings of the National Academy of Sciences. 105(26). 8866–8871. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact